Four products, four routes, four figures
The homepage price block gives a starting figure for a semaglutide injection, a semaglutide oral dissolving tablet, a tirzepatide injection and a tirzepatide oral dissolving tablet, and labels each one once-weekly or daily.
Twenty-seven of the one hundred and fifty-eight sellers here price an oral route at all. Pricing both routes for both molecules, on a public page with no intake, is at the useful end of that group.
The site-wide promotional band and the product block carry the same figure for the cheapest product, so the two surfaces agree — which is not a given on this roster.
Three companies and a fourth brand
The privacy policy opens by naming a limited liability company doing business under the site's brand. Further down, it defines its first-person pronouns as referring to a completely different brand name, and states that brand is owned by a corporation of the site's name registered in Delaware, at a Georgia address.
So one policy document names a limited liability company, a corporation and an unexplained fourth brand, and applies the pronouns of the document to the brand that appears nowhere else on the site.
All of it is recorded and none of it is resolved. A reader who wants to know which of these three entities takes their money cannot learn it from this page.
Starting figures with nothing behind them
All four figures are starting rates. No dose ladder is published and nothing states what a higher strength costs, which is the standard gap on a four-SKU price block.
Brand-name products are named in the site copy and none carries a figure. Nothing is said about a membership either way, so that position is recorded as unstated.
No pharmacy is named, no individual clinician is named, and no service area is published.
OnlyRx's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $179/mostarting at; a site-wide promotional band carries the same figure as "Summer Promo! Only $179 + Fast, Free Shipping" | September 2026source |
| Semaglutide (compounded-oral) | $249/mostarting at, for the daily oral tablet - seventy dollars above the injection of the same drug | September 2026source |
| Tirzepatide (compounded) | $249/mostarting at, for the weekly injection | September 2026source |
| Tirzepatide (compounded-oral) | $279/mostarting at, the highest of the four figures on the page | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 158 providers reviewed here are paid partners today; the other 154 are not. See how this works.
See OnlyRx's current price →Good fit if
- Buyers who want an oral and an injectable priced separately for both molecules.
- Readers who want a price on a public page rather than behind an intake.
- People who want the route stated beside the figure.
Look elsewhere if
- Anyone who needs to know which of three companies operates the site.
- Buyers who want to know what a higher dose costs.
- Readers who need the pharmacy or the prescriber named.
- People who need a published service area.
How this review was verified
- Read the homepage and the privacy policy on 6 September 2026, with a nonsense-path control on the host in the same run that returned a clean not-found status.
- Joined adjacent text nodes before matching prices; the product block splits each label and figure across separate elements.
- Recorded all three company names and the fourth brand from the single document that carries them, without resolving which is the operator.
- Checked that the promotional band and the product block carry the same figure, and they do.
- Screened the operating entity and the brand name against FDA's live warning-letter datatable, carrying a known letter as a positive control and a nonsense string as a negative control in the same pass; the positive control returned its letter and the negative returned nothing. Neither the entity nor the brand returned one. Untitled letters are published separately and were not searched, so the supportable claim is that no warning letter was found.